Mauricio García-Saenz-de-Sicilia
Associate Professor, Division Chief
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Mauricio García-Saenz-de-Sicilia's research focuses on the medical management of advanced liver disease and liver transplantation. His work investigates strategies for risk stratification in liver transplant candidates, including the use of computed tomography coronary calcium scores for coronary artery disease assessment and cystatin C for evaluating kidney dysfunction and survival. García-Saenz-de-Sicilia also studies endoscopic management techniques for gastric neoplasms and the role of alpha-fetoprotein in liver allocation for transplantation. His recent publications address emerging areas such as endohepatology and the application of drug-coated balloons in cardiovascular interventions within the context of solid organ transplantation. He has authored 42 publications, with a total of 475 citations, and holds an h-index of 12. García-Saenz-de-Sicilia collaborates with researchers at the University of Arkansas for Medical Sciences, including Ragesh B. Thandassery and Sushma Bhusal.
Metrics
- h-index: 12
- Publications: 42
- Citations: 482
Selected Publications
-
Drug-coated balloon angioplasty with a focus on solid organ transplantation: a promising paradigm shift in cardiovascular interventions (2026)
-
Metastatic Jejunal Adenocarcinoma in the Hepatobiliary Limb Post-Liver Transplant: Diagnostic Challenges in a Patient with Roux-en-Y Gastric Bypass (2024)
-
Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study (2024)
-
Prospective evaluation of cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates (2024)
-
Recent advances in endoscopic management of gastric neoplasms (2023)
-
Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future (2022)
-
Endohepatology: current status and perspectives (2022)
Collaboration Network
Top Collaborators
- Use of Computed Tomography Coronary Calcium Score for Coronary Artery Disease Risk Stratification During Liver Transplant Evaluation
- Prospective evaluation of cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates
- Mastering Core Recommendations during HEPAtology ROUNDS in Patients with Advanced Chronic Liver Disease
- Recent advances in endoscopic management of gastric neoplasms
- Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Recent advances in endoscopic management of gastric neoplasms
- Mo1684: NON-INVASIVE STRATEGY TO DIAGNOSE CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH MASLD CAN MISS SCREENING AND DIAGNOSIS OF BARRETT’S ESOPHAGUS IN HIGH-RISK PATIENTS IRRESPECTIVE OF GASTROESOPHAGEAL REFLUX SYMPTOMS
- Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in <scp>COVID</scp>‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
- Tu1830: SAFETY OF INFLAMMATORY BOWEL DISEASE ADVANCED THERAPIES IN PATIENTS WITH CIRRHOSIS.
- Mo1684: NON-INVASIVE STRATEGY TO DIAGNOSE CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH MASLD CAN MISS SCREENING AND DIAGNOSIS OF BARRETT’S ESOPHAGUS IN HIGH-RISK PATIENTS IRRESPECTIVE OF GASTROESOPHAGEAL REFLUX SYMPTOMS
Similar Researchers
Based on overlapping research topics